159 related articles for article (PubMed ID: 7511329)
1. Varying populations of CD59-negative, partly positive, and normally positive blood cells in different cell lineages in peripheral blood of paroxysmal nocturnal hemoglobinuria patients.
Fujioka S; Yamada T
Am J Hematol; 1994 Feb; 45(2):122-7. PubMed ID: 7511329
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric analysis of glycosylphosphatidyl-inositol-anchored proteins to assess paroxysmal nocturnal hemoglobinuria clone size.
Piedras J; López-Karpovitch X
Cytometry; 2000 Aug; 42(4):234-8. PubMed ID: 10934342
[TBL] [Abstract][Full Text] [Related]
3. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
Fujioka S; Yamada T
Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
[TBL] [Abstract][Full Text] [Related]
4. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
Fujioka S; Yamada T
Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF.
Shichishima T; Terasawa T; Saitoh Y; Hashimoto C; Ohto H; Maruyama Y
Br J Haematol; 1993 Oct; 85(2):378-86. PubMed ID: 7506570
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.
Dworacki G; Sikora J; Mizera-Nyczak E; Trybus M; Mozer-Lisewska I; Czyz A; Zeromski J
Folia Histochem Cytobiol; 2005; 43(2):117-20. PubMed ID: 16044949
[TBL] [Abstract][Full Text] [Related]
7. Blood cell flow cytometry in paroxysmal nocturnal hemoglobinuria: a tool for measuring the extent of the PNH clone.
Alfinito F; Del Vecchio L; Rocco S; Boccuni P; Musto P; Rotoli B
Leukemia; 1996 Aug; 10(8):1326-30. PubMed ID: 8709638
[TBL] [Abstract][Full Text] [Related]
8. Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Nagakura S; Nakakuma H; Horikawa K; Hidaka M; Kagimoto T; Kawakita M; Tomita M; Takatsuki K
Am J Hematol; 1993 May; 43(1):14-8. PubMed ID: 7686331
[TBL] [Abstract][Full Text] [Related]
9. A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.
Oelschlaegel U; Besson I; Arnoulet C; Sainty D; Nowak R; Naumann R; Bux Y; Ehninger G
Clin Lab Haematol; 2001 Apr; 23(2):81-90. PubMed ID: 11488846
[TBL] [Abstract][Full Text] [Related]
10. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.
Hall SE; Rosse WF
Blood; 1996 Jun; 87(12):5332-40. PubMed ID: 8652849
[TBL] [Abstract][Full Text] [Related]
11. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of paroxysmal nocturnal hemoglobinuria in peripheral blood and bone marrow with six-color flow cytometry.
Yang HS; Yang M; Li X; Tugulea S; Dong H
Biomark Med; 2013 Feb; 7(1):99-111. PubMed ID: 23387491
[TBL] [Abstract][Full Text] [Related]
13. Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients: a flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
Navenot JM; Bernard D; Harousseau JL; Muller JY; Blanchard D
Leuk Lymphoma; 1996 Mar; 21(1-2):143-51. PubMed ID: 8907282
[TBL] [Abstract][Full Text] [Related]
14. [Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Forés R; Alcocer M; Cabrera R; Sanjuán I; Briz M; Lago C; Fernández MN
Sangre (Barc); 1999 Jun; 44(3):199-203. PubMed ID: 10481581
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD59 on lymphocyte and the subsets and its potential clinical application for paroxysmal nocturnal hemoglobinuria diagnosis.
Cui W; Fan Y; Yang M; Zhang Z
Clin Lab Haematol; 2004 Apr; 26(2):95-100. PubMed ID: 15053802
[TBL] [Abstract][Full Text] [Related]
16. Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow.
Olteanu H; Karandikar NJ; McKenna RW; Xu Y
Am J Clin Pathol; 2006 Nov; 126(5):781-8. PubMed ID: 17050075
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PI (phosphatidylinositol)-anchoring antigens in a patient of paroxysmal nocturnal hemoglobinuria (PNH) reveals deficiency of 1F5 antigen (CD59), a new complement-regulatory factor.
Taguchi R; Funahashi Y; Ikezawa H; Nakashima I
FEBS Lett; 1990 Feb; 261(1):142-6. PubMed ID: 1689670
[TBL] [Abstract][Full Text] [Related]
18. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
[TBL] [Abstract][Full Text] [Related]
19. Paroxysmal nocturnal hemoglobinuria testing by flow cytometry. Evaluation of the REDQUANT and CELLQUANT kits.
Hsi ED
Am J Clin Pathol; 2000 Nov; 114(5):798-806. PubMed ID: 11068556
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic analysis of affected peripheral erythroid for CD59 in paroxysmal nocturnal hemoglobinuria.
Cui W; Lin Q; Zhang Z
Chin Med J (Engl); 2002 Feb; 115(2):206-8. PubMed ID: 11940332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
